NASDAQ$BTTC

Black Titan Corp · Q3 2014 earnings

Q3 2014 earnings · Reported Nov 13, 2014 (12 years ago) · Investor relations

Nov 13Sep 30, 2014

Total Revenue

$911K

Previous: -$120K+857.1%

EPS (adj)

$0.30

Previous: -$0.60+150.0%

Capital Expenditures

$8K

Previous: -$1K+900.0%

Net Income

$716K

Previous: $131K+445.6%

Operating Income

-$738K

Previous: $142K-619.3%

Gross Profit

$129K

Previous: $599K-78.5%

Cash & Equivalents

$7.45M

Previous: $570K+1206.6%

Total Assets

$13.2M

Previous: $8.1M+63.1%

Stock-Based Comp

$71K

Previous: $21K+238.1%

Titan Pharmaceuticals · Revenue · Quarterly

$911K

Q3 2014-857.1%vs Q3 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation